3/11
02:21 pm
rapp
Rating for RAPP
Low
Report
Rating for RAPP
3/11
11:08 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
3/11
11:08 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
3/10
10:15 am
rapp
Rapport Therapeutics (RAPP) had its "market outperform" rating reaffirmed by Citigroup Inc..
Medium
Report
Rapport Therapeutics (RAPP) had its "market outperform" rating reaffirmed by Citigroup Inc..
3/9
11:05 am
rapp
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research.
Low
Report
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research.
2/2
09:46 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
2/2
09:46 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
2/2
07:00 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $43.00 price target on the stock.
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $43.00 price target on the stock.
2/2
05:58 am
rapp
Rapport Therapeutics initiated with an Overweight at Wells Fargo
Medium
Report
Rapport Therapeutics initiated with an Overweight at Wells Fargo
2/2
05:58 am
rapp
Rapport Therapeutics initiated with an Overweight at Wells Fargo
Medium
Report
Rapport Therapeutics initiated with an Overweight at Wells Fargo
1/8
07:17 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..